je.st
news
Valeant Pharmaceuticals Intl Inc (VRX) Receives Underperform Rating from Wells Fargo
2016-04-15 22:46:50| Biotech - Topix.net
's stock had its "underperform" rating restated by research analysts at Wells Fargo in a report issued on Friday, MarketBeat.com reports. Shares of Valeant Pharmaceuticals Intl traded down 0.03% during midday trading on Friday, reaching $32.35.
Tags: rating
receives
wells
intl
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||